Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation
NCT ID: NCT04980924
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
547 participants
OBSERVATIONAL
1992-01-01
1997-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event
NCT05073666
Evaluation of the Effectiveness of Intensive Medical Follow-up with an Advanced Practice Nurse Compared with Medical Follow-up Alone in Non-severe Pulmonary Embolism.
NCT06598930
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
NCT05481242
Prevalence of Pulmonary Embolism in ICU
NCT01457963
Pulmonary Embolism After Liver Resection
NCT01486511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Embolism without reccurence or complication
Pulmonary Embolism without reccurence or complication
no intervention
no intervention
Pulmonary Embolism with reccurence or complication
Pulmonary Embolism with reccurence or complication, in particular occurrence of pulmonary hypertension.
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acceptation to enter in the cohorte survey
Exclusion Criteria
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nice University Hospital
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ferrari E, Fourrier E, Asarisi F, Heme N, Redjimi N, Berkane N, Labbaoui M, Breittmayer JP, Bun SS, Moceri P, Squara F. Is pulmonary embolism recurrence linked with the severity of the first event? A French retrospective cohort study. BMJ Open. 2021 Sep 29;11(9):e050910. doi: 10.1136/bmjopen-2021-050910.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21cardio01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.